Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4265401 | 0.94 | LPL (0.33) | — | |
| SCHEMBL13636791 | 0.88 | RELA (0.33) | ALDH1A1MAPT | |
| SCHEMBL18194207 | 0.85 | KDM4E (0.31) | KDM4EALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL4374187 | 0.84 | LPL (0.30) | — | |
| SCHEMBL17011009 | 0.84 | ALDH1A1 (0.41) | KDM4EALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL17279021 | 0.82 | ALDH1A1 (0.48) | KDM4EALDH1A1CYP3A4MAPTTDP1 | |
| SCHEMBL13855288 | 0.80 | ESR1 (0.41) | KDM4EALDH1A1MAPT | |
| SCHEMBL13855286 | 0.80 | KDM4E (0.33) | KDM4EALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL4262348 | 0.77 | LPL (0.40) | — | |
| SCHEMBL9947795 | 0.74 | ALDH1A1 (0.35) | KDM4EALDH1A1CYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9871213-B2 | Organic electroluminescent device | MERCK PATENT GMBH (DE) | 2018-01-16 | — | — | US | disclosed |
| US-9871213-B2 | Organic electroluminescent device | MERCK PATENT GMBH (DE) | 2018-01-16 | — | — | US | disclosed |
| US-20160322570-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2016-11-03 | — | — | US | disclosed |
| US-20160322570-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2016-11-03 | — | — | US | disclosed |
| US-9403849-B2 | Organic electroluminescent device and boric acid and borinic acid derivatives used therein | MERCK PATENT GMBH (DE) | 2016-08-02 | — | — | US | disclosed |
| US-9403849-B2 | Organic electroluminescent device and boric acid and borinic acid derivatives used therein | MERCK PATENT GMBH (DE) | 2016-08-02 | — | — | US | disclosed |
| US-20150322091-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND BORIC ACID AND BORINIC ACID DERIVATIVES USED THEREIN | MERCK PATENT GMBH (DE) | 2015-11-12 | — | — | US | disclosed |
| US-20150322091-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND BORIC ACID AND BORINIC ACID DERIVATIVES USED THEREIN | MERCK PATENT GMBH (DE) | 2015-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160322570-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | OR10J3, BTD, ERG | KDM4E 2795/4885ALDH1A1 1034/4885CYP1A2 3762/4885 |
| US-20150322091-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND BORIC ACID AND BORINIC ACID DERIVATIVES USED THEREIN | BTD, ERG, OR10J3 | KDM4E 3364/4885ALDH1A1 857/4885CYP1A2 3474/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.